Vidcast: https://www.instagram.com/p/C2f2SWurO1F/

The psychoactive drug ibogaine can curb symptoms of post-traumatic stress disorder by some 88%. This the conclusion of s Stanford University study of 30 Gulf War special ops veterans.

Administration of ibogaine for only one month also produced an 87% reduction in depressive symptoms, an 81% drop in anxiety, and marked improvements in concentration, memory, information processing, and tendencies toward impulsive behavior. Every vet receiving the drug showed improvement. Previous studies with other medications have failed to yield such dramatic improvements for PTSD sufferers.

The bad news: while ibogaine is available in Canada and Mexico, it is a

restricted Schedule I drug in the US and should only be administered under close supervision. Ibocaine can also trigger cardiac issues, and must be administered with magnesium supplementation.

This small, preliminary study requires repetition on a larger scale to confirm its effectiveness and to begin understanding how the drug works. Nonetheless, the results are exciting and may offer hope to those with treatment-resistant PTSD.

https://www.nature.com/articles/s41591-023-02705-w

#ptsd #ibogaine #magnesium #depression #veterans

New Drug Therapy For PTSD

Dr. Howard Smith Reports